Edgestream Partners L.P. lowered its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 39.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 94,748 shares of the real estate investment trust’s stock after selling 61,648 shares during the period. Edgestream Partners L.P.’s holdings in Sabra Healthcare REIT were worth $1,747,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of SBRA. State of Michigan Retirement System raised its stake in shares of Sabra Healthcare REIT by 1.1% during the 2nd quarter. State of Michigan Retirement System now owns 57,249 shares of the real estate investment trust’s stock worth $1,056,000 after purchasing an additional 600 shares during the period. Cherry Creek Investment Advisors Inc. raised its position in Sabra Healthcare REIT by 4.4% in the second quarter. Cherry Creek Investment Advisors Inc. now owns 19,074 shares of the real estate investment trust’s stock worth $352,000 after acquiring an additional 802 shares during the period. Ethos Financial Group LLC boosted its stake in Sabra Healthcare REIT by 1.3% in the second quarter. Ethos Financial Group LLC now owns 66,658 shares of the real estate investment trust’s stock valued at $1,229,000 after acquiring an additional 835 shares during the last quarter. Exchange Traded Concepts LLC grew its position in shares of Sabra Healthcare REIT by 2.0% during the 2nd quarter. Exchange Traded Concepts LLC now owns 48,718 shares of the real estate investment trust’s stock valued at $898,000 after acquiring an additional 936 shares during the period. Finally, LPL Financial LLC increased its stake in shares of Sabra Healthcare REIT by 0.8% during the 1st quarter. LPL Financial LLC now owns 126,268 shares of the real estate investment trust’s stock worth $2,206,000 after purchasing an additional 957 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.
Wall Street Analysts Forecast Growth
SBRA has been the topic of several research analyst reports. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, October 8th. UBS Group initiated coverage on Sabra Healthcare REIT in a research note on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 target price on the stock. Cantor Fitzgerald initiated coverage on Sabra Healthcare REIT in a research note on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price target for the company. National Bankshares set a $22.00 price objective on Sabra Healthcare REIT in a research note on Friday, October 17th. Finally, Truist Financial increased their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research report on Tuesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $20.88.
Sabra Healthcare REIT Stock Performance
NASDAQ:SBRA opened at $19.28 on Friday. The business’s fifty day moving average is $18.43 and its 200 day moving average is $18.44. The firm has a market cap of $4.81 billion, a price-to-earnings ratio of 26.78, a PEG ratio of 1.21 and a beta of 0.67. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $19.97.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The business had revenue of $190.04 million during the quarter, compared to analyst estimates of $193.44 million. During the same quarter in the previous year, the firm earned $0.37 EPS. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Monday, November 17th were paid a $0.30 dividend. The ex-dividend date was Monday, November 17th. This represents a $1.20 annualized dividend and a yield of 6.2%. Sabra Healthcare REIT’s dividend payout ratio is currently 166.67%.
Sabra Healthcare REIT Company Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Further Reading
- Five stocks we like better than Sabra Healthcare REIT
- Roth IRA Calculator: Calculate Your Potential Returns
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- Investing In Preferred Stock vs. Common Stock
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
